Technical advancement and practical considerations of LC-MS/MS-based methods for host cell protein identification and quantitation to support process development

References

• Jones M, Palackal N, Wang F, Gaza-Bulseco G, Hurkmans K, Zhao Y, Chitikila C, Clavier S, Liu S, Menesale E, et al. “High-risk” host cell proteins (HCPs): a multi-company collaborative view. Biotechnol Bioeng. 2021;118(8):2870–15. doi:10.1002/bit.27808.
   PubMed Web of Science ®Google Scholar
• FDA. Points to consider in the manufacture and testing of monoclonal antibody products for human use. FDA-1994-D-0318 1994.
   Google Scholar
• EMA. DNA and host cell protein impurities, routine testing versus validation studies. 1997; CPMP/BWP/382/97.
   Google Scholar
• Pharmacopeia US. 2016. Residual host cell protein measurement in biopharmaceuticals. USP. Published General Chapter 1132. 39:1416–36.
   Google Scholar
• Pharmacopeia EU. Host-cell protein assays. European pharmacopoeia monograph 2.6.34. 2017;4:20634.
   Google Scholar
• Zhu-Shimoni J, Yu C, Nishihara J, Wong RM, Gunawan F, Lin M, Krawitz D, Liu P, Sandoval W, Vanderlaan M. Host cell protein testing by ELISAs and the use of orthogonal methods. Biotechnol Bioeng. 2014;111(12):2367–79. doi:10.1002/bit.25327.
   PubMed Web of Science ®Google Scholar
• Yang F, Li D, Kufer R, Cadang L, Zhang J, Dai L, Guo J, Wohlrab S, Greenwood-Goodwin M, Shen A, et al. Versatile LC–MS-Based workflow with robust 0.1 ppm sensitivity for identifying residual HCPs in biotherapeutic products. Anal Chem. 2022;94(2):723–31. doi:10.1021/acs.analchem.1c03095.
   PubMed Web of Science ®Google Scholar
• Urabe M, Ding C, Kotin RM. Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum Gene Ther. 2002;13(16):1935–43. doi:10.1089/10430340260355347.
   PubMed Web of Science ®Google Scholar
• Kulagina N, Besseau S, Godon C, Goldman GH, Papon N, Courdavault V. Yeasts as biopharmaceutical production platforms. Front Fungal Biol. 2021;2. doi:10.3389/ffunb.2021.733492.
   PubMedGoogle Scholar
• Reisinger V, Toll H, Mayer RE, Visser J, Wolschin F. A mass spectrometry-based approach to host cell protein identification and its application in a comparability exercise. Anal Biochem. 2014;463:1–6. doi:10.1016/j.ab.2014.06.005.
   PubMed Web of Science ®Google Scholar
• Molden R, Hu M, Yen ES, Saggese D, Reilly J, Mattila J, Qiu H, Chen G, Bak H, Li N. Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development. MAbs. 2021;13(1):1955811. doi:10.1080/19420862.2021.1955811.
   PubMed Web of Science ®Google Scholar
• Graf T, Tomlinson A, Yuk IH, Kufer R, Spensberger B, Falkenstein R, Shen A, Li H, Duan D, Liu W, et al. Identification and characterization of polysorbate-degrading enzymes in a monoclonal antibody formulation. J Pharm Sci. 2021;110(11):3558–67. doi:10.1016/j.xphs.2021.06.033.
   PubMed Web of Science ®Google Scholar
• Walker DE, Yang F, Carver J, Joe K, Michels DA, Yu XC. A modular and adaptive mass spectrometry-based platform for support of bioprocess development toward optimal host cell protein clearance. MAbs. 2017;9(4):654–63. doi:10.1080/19420862.2017.1303023.
   PubMed Web of Science ®Google Scholar
• Jin M, Szapiel N, Zhang J, Hickey J, Ghose S. Profiling of host cell proteins by two-dimensional difference gel electrophoresis (2D-DIGE): implications for downstream process development. Biotechnol Bioeng. 2010;105(2):306–16. doi:10.1002/bit.22532.
   PubMed Web of Science ®Google Scholar
• Hogwood CEM, Bracewell DG, Smales CM. Measurement and control of host cell proteins (HCPs) in CHO cell bioprocesses. Curr Opin Biotechnol. 2014;30:153–60. doi:10.1016/j.copbio.2014.06.017.
   PubMed Web of Science ®Google Scholar
• The antibody society, Inc. Antibody therapeutics approved or in regulatory review in the EU or US. [assessed Mar 8, 2023]. www.antibodysociety.org/antibody-therapeutics-product-data.
   Google Scholar
• Falkenberg H, Waldera-Lupa DM, Vanderlaan M, Schwab T, Krapfenbauer K, Studts JM, Flad T, Waerner T. Mass spectrometric evaluation of upstream and downstream process influences on host cell protein patterns in biopharmaceutical products. Biotechnol Prog. 2019;35(3):e2788. doi:10.1002/btpr.2788.
   PubMed Web of Science ®Google Scholar
• Bracewell DG, Francis R, Smales CM. The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control. Biotechnol Bioeng. 2015;112(9):1727–37. doi:10.1002/bit.25628.
   PubMed Web of Science ®Google Scholar
• Vanderlaan M, Zhu-Shimoni J, Lin S, Gunawan F, Waerner T, Van Cott KE. Experience with host cell protein impurities in biopharmaceuticals. Biotechnol Prog. 2018;34(4):828–37. doi:10.1002/btpr.2640.
   PubMed Web of Science ®Google Scholar
• Bracewell DG, Smith V, Delahaye M, Smales CM. Analytics of host cell proteins (HCPs): lessons from biopharmaceutical mAb analysis for gene therapy products. Curr Opin Biotechnol. 2021;71:98–104. doi:10.1016/j.copbio.2021.06.026.
   PubMed Web of Science ®Google Scholar
• Krutzke L, Rosler R, Allmendinger E, Engler T, Wiese S, Kochanek S. Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine. Elife. 2022;11:11. doi:10.7554/eLife.78513.
   Web of Science ®Google Scholar
• Yuk IH, Nishihara J, Walker D Jr., Huang E, Gunawan F, Subramanian J, Pynn AFJ, Yu XC, Zhu-Shimoni J, Vanderlaan M, et al. More similar than different: host cell protein production using three null CHO cell lines. Biotechnol Bioeng. 2015;112(10):2068–83. doi:10.1002/bit.25615.
   PubMed Web of Science ®Google Scholar
• Hamaker NK, Min L, Lee KH. Comprehensive assessment of host cell protein expression after extended culture and bioreactor production of CHO cell lines. Biotechnol Bioeng. 2022;119(8):2221–38. doi:10.1002/bit.28128.
   PubMed Web of Science ®Google Scholar
• Chiu J, Valente KN, Levy NE, Min L, Lenhoff AM, Lee KH. Knockout of a difficult-to-remove CHO host cell protein, lipoprotein lipase, for improved polysorbate stability in monoclonal antibody formulations. Biotechnol Bioeng. 2017;114(5):1006–15. doi:10.1002/bit.26237.
   PubMed Web of Science ®Google Scholar
• Carver J, Kern M, Ko P, Greenwood-Goodwin M, Yu XC, Duan D, Tang D, Misaghi S, Auslaender S, Haley B, et al. A ribonucleoprotein-based decaplex CRISPR/Cas9 knockout strategy for CHO host engineering. Biotechnol Prog. 2022;38(1):e3212. doi:10.1002/btpr.3212.
   PubMed Web of Science ®Google Scholar
• Vanderlaan M, Sandoval W, Liu P, Nishihara J, Tsui G, Lin M, Gunawan F, Parker S, Wong RM, Low J , et al. Hamster phospholipase B-like 2 (PLBL2): A host-cell protein impurity in therapeutic monoclonal antibodies derived from Chinese hamster ovary cells. BioProcess International. 2015;13(4):18–29.
   Google Scholar
• Zhang Q, Goetze AM, Cui H, Wylie J, Trimble S, Hewig A, Flynn GC. Comprehensive tracking of host cell proteins during monoclonal antibody purifications using mass spectrometry. MAbs. 2014;6(3):659–70. doi:10.4161/mabs.28120.
   PubMed Web of Science ®Google Scholar
• Gilgunn S, El-Sabbahy H, Albrecht S, Gaikwad M, Corrigan K, Deakin L, Jellum G, Bones J. Identification and tracking of problematic host cell proteins removed by a synthetic, highly functionalized nonwoven media in downstream bioprocessing of monoclonal antibodies. J Chromatogr A. 2019;1595:28–38. doi:10.1016/j.chroma.2019.02.056.
   PubMed Web of Science ®Google Scholar
• Chen Y, Xu CF, Stanley B, Evangelist G, Brinkmann A, Liu S, McCarthy S, Xiong L, Jones E, Sosic Z, et al. A highly sensitive LC-MS/MS method for targeted quantitation of lipase host cell proteins in biotherapeutics. J Pharm Sci. 2021;110(12):3811–18. doi:10.1016/j.xphs.2021.08.024.
   PubMed Web of Science ®Google Scholar
• Pilely K, Johansen MR, Lund RR, Kofoed T, Jorgensen TK, Skriver L, Mørtz E. Monitoring process-related impurities in biologics–host cell protein analysis. Anal Bioanal Chem. 2022;414(2):747–58. doi:10.1007/s00216-021-03648-2.
   PubMed Web of Science ®Google Scholar
• Wohlrab S, Wiedmann M, Aschner M, Reusch D, Bulau P, Haindl M. Tracking host cell proteins while biopharmaceutical manufacturing: advanced methodologies to improve product quality. Am Pharm Rev. 2018;21:36–39.
   Google Scholar
• Gunawan F, Nishihara J, Liu P, Sandoval W, Vanderlaan M, Zhang H, Krawitz D. Comparison of platform host cell protein ELISA to process-specific host cell protein ELISA. Biotechnol Bioeng. 2018;115(2):382–89. doi:10.1002/bit.26466.
   PubMed Web of Science ®Google Scholar
• Hu M, Molden R, Hu Y, Huang Y, Qiu H, Li N. Host cell protein identification in monoclonal antibody high molecular weight species. J Chromatogr B Analyt Technol Biomed Life Sci. 2022;1210:123448. doi:10.1016/j.jchromb.2022.123448.
   PubMed Web of Science ®Google Scholar
• Hecht ES, Mehta S, Wecksler AT, Aguilar B, Swanson N, Phung W, Dubey Kelsoe A, Benner WH, Tesar D, Kelley RF, et al. Insights into ultra-low affinity lipase-antibody noncovalent complex binding mechanisms. MAbs. 2022;14(1):2135183. doi:10.1080/19420862.2022.2135183.
   PubMed Web of Science ®Google Scholar
• Seisenberger C, Graf T, Haindl M, Wegele H, Wiedmann M, Wohlrab S. Questioning coverage values determined by 2D western blots: a critical study on the characterization of anti-HCP ELISA reagents. Biotechnol Bioeng. 2021;118(3):1116–26. doi:10.1002/bit.27635.
   PubMed Web of Science ®Google Scholar
• Waldera-Lupa DM, Jasper Y, Kohne P, Schwichtenhovel R, Falkenberg H, Flad T, Happersberger P, Reisinger B, Dehghani A, Moussa R, et al. Host cell protein detection gap risk mitigation: quantitative IAC-MS for ELISA antibody reagent coverage determination. MAbs. 2021;13(1):1955432. doi:10.1080/19420862.2021.1955432.
   PubMed Web of Science ®Google Scholar
• Henry SM, Sutlief E, Salas-Solano O, Valliere-Douglass J. ELISA reagent coverage evaluation by affinity purification tandem mass spectrometry. MAbs. 2017;9(7):1065–75. doi:10.1080/19420862.2017.1349586.
   PubMed Web of Science ®Google Scholar
• Seisenberger C, Graf T, Haindl M, Wegele H, Wiedmann M, Wohlrab S. Toward optimal clearance: a universal affinity-based mass spectrometry approach for comprehensive ELISA reagent coverage evaluation and HCP hitchhiker analysis. Biotechnol Prog. 2022;38(3):e3244. doi:10.1002/btpr.3244.
   PubMed Web of Science ®Google Scholar
• Rumachik NG, Malaker SA, Poweleit N, Maynard LH, Adams CM, Leib RD, Cirolia G, Thomas D, Stamnes S, Holt K, et al. Methods matter: standard production platforms for recombinant AAV produce chemically and functionally distinct vectors. Mol Ther Methods Clin Dev. 2020;18:98–118. doi:10.1016/j.omtm.2020.05.018.
   PubMed Web of Science ®Google Scholar
• Aloor A, Zhang J, Gashash EA, Parameswaran A, Chrzanowski M, Ma C, Diao Y, Wang P, Xiao W. Site-specific N-glycosylation on the AAV8 capsid protein. Viruses. 2018;10(11):644. doi:10.3390/v10110644.
   PubMed Web of Science ®Google Scholar
• Johnson S, Wheeler JX, Thorpe R, Collins M, Takeuchi Y, Zhao Y. Mass spectrometry analysis reveals differences in the host cell protein species found in pseudotyped lentiviral vector. Biologicals. 2018;52:7. doi:10.1016/j.biologicals.2017.12.005.
   Web of Science ®Google Scholar
• Trauchessec M, Hesse AM, Kraut A, Berard Y, Herment L, Fortin T, Bruley C, Ferro M, Manin C. An innovative standard for LC-MS-based HCP profiling and accurate quantity assessment: application to batch consistency in viral vaccine samples. Proteomics. 2021;21(5):e2000152. doi:10.1002/pmic.202000152.
   PubMed Web of Science ®Google Scholar
• Doneanu CE, Chen W. Analysis of host-cell proteins in biotherapeutic proteins by LC/MS approaches. Methods Mol Biol. 2014;1129:341–50. doi:10.1007/978-1-62703-977-2_25.
   PubMedGoogle Scholar
• Levy NE, Valente KN, Choe LH, Lee KH, Lenhoff AM. Identification and characterization of host cell protein product-associated impurities in monoclonal antibody bioprocessing. Biotechnol Bioeng. 2014;111(5):904–12. doi:10.1002/bit.25158.
   PubMed Web of Science ®Google Scholar
• Doneanu CE, Anderson M, Williams BJ, Lauber MA, Chakraborty A, Chen W. Enhanced detection of low-abundance host cell protein impurities in high-purity monoclonal antibodies down to 1 ppm using ion mobility mass spectrometry coupled with multidimensional liquid chromatography. Anal Chem. 2015;87(20):10283–91. doi:10.1021/acs.analchem.5b02103.
   PubMed Web of Science ®Google Scholar
• Aebersold R, Mann M. Mass-spectrometric exploration of proteome structure and function. Nature. 2016;537(7620):347–55. doi:10.1038/nature19949.
   PubMed Web of Science ®Google Scholar
• Bomans K, Lang A, Roedl V, Adolf L, Kyriosoglou K, Diepold K, Eberl G, Mølhøj M, Strauss U, Schmalz C, et al. Identification and monitoring of host cell proteins by mass spectrometry combined with high performance immunochemistry testing. PLos One. 2013;8(11):e81639. doi:10.1371/journal.pone.0081639.
   PubMed Web of Science ®Google Scholar
• Thompson JH, Chung WK, Zhu M, Tie L, Lu Y, Aboulaich N, Strouse R, Mo WD. Improved detection of host cell proteins (HCPs) in a mammalian cell-derived antibody drug using liquid chromatography/mass spectrometry in conjunction with an HCP-enrichment strategy. Rapid Commun Mass Spectrom. 2014;28(8):855–60. doi:10.1002/rcm.6854.
   PubMed Web of Science ®Google Scholar
• Madsen JA, Farutin V, Carbeau T, Wudyka S, Yin Y, Smith S, Anderson J, Capila I. Toward the complete characterization of host cell proteins in biotherapeutics via affinity depletions, LC-MS/MS, and multivariate analysis. MAbs. 2015;7(6):1128–37. doi:10.1080/19420862.2015.1082017.
   PubMed Web of Science ®Google Scholar
• Soderquist RG, Trumbo M, Hart RA, Zhang Q, Flynn GC. Development of advanced host cell protein enrichment and detection strategies to enable process relevant spike challenge studies. Biotechnol Prog. 2015;31(4):983–89. doi:10.1002/btpr.2114.
   PubMed Web of Science ®Google Scholar
• Huang L, Wang N, Mitchell CE, Brownlee T, Maple SR, De Felippis MR. A novel sample preparation for shotgun proteomics characterization of HCPs in antibodies. Anal Chem. 2017;89(10):5436–44. doi:10.1021/acs.analchem.7b00304.
   PubMed Web of Science ®Google Scholar
• Kufer R, Haindl M, Wegele H, Wohlrab S. Evaluation of peptide fractionation and native digestion as two novel sample preparation workflows to improve HCP characterization by LC–MS/MS. Anal Chem. 2019;91(15):9716–23. doi:10.1021/acs.analchem.9b01259.
   PubMed Web of Science ®Google Scholar
• Chen IH, Xiao H, Daly T, Li N. Improved host cell protein analysis in monoclonal antibody products through molecular weight cutoff enrichment. Anal Chem. 2020;92(5):3751–57. doi:10.1021/acs.analchem.9b05081.
   PubMed Web of Science ®Google Scholar
• Zhang S, Xiao H, Li N. Ultrasensitive method for profiling host cell proteins by coupling limited digestion to ProteoMiner technology. Anal Biochem. 2022;657:114901. doi:10.1016/j.ab.2022.114901.
   PubMed Web of Science ®Google Scholar
• Deng Y, Gruppen H, Wierenga PA. Comparison of Protein Hydrolysis Catalyzed By Bovine, Porcine, And Human Trypsins. J Agric Food Chem. 2018;66(16):4219–32. doi:10.1021/acs.jafc.8b00679.
   PubMed Web of Science ®Google Scholar
• Nie S, Greer T, O’Brien Johnson R, Zheng X, Torri A, Li N. Simple and sensitive method for deep profiling of host cell proteins in therapeutic antibodies by combining ultra-low trypsin concentration digestion, long chromatographic gradients, and boxcar mass spectrometry acquisition. Anal Chem. 2021;93(10):4383–90. doi:10.1021/acs.analchem.0c03931.
   PubMed Web of Science ®Google Scholar
• Li D, Farchone A, Zhu Q, Macchi F, Walker DE, Michels DA, Yang F. Fast, robust, and sensitive identification of residual host cell proteins in recombinant monoclonal antibodies using sodium deoxycholate assisted digestion. Anal Chem. 2020;92(17):11888–94. doi:10.1021/acs.analchem.0c02258.
   PubMed Web of Science ®Google Scholar
• Wang Q, Slaney TR, Wu W, Ludwig R, Tao L, Leone A. Enhancing host-cell protein detection in protein therapeutics using HILIC enrichment and proteomic analysis. Anal Chem. 2020;92(15):10327–35. doi:10.1021/acs.analchem.0c00360.
   PubMed Web of Science ®Google Scholar
• Zhao B, Abdubek P, Zhang S, Xiao H, Li N. Analysis of host cell proteins in monoclonal antibody therapeutics through size exclusion chromatography. Pharm Res. 2022;39(11):3029–37. doi:10.1007/s11095-022-03381-0.
   PubMed Web of Science ®Google Scholar
• Mörtstedt H, Makower Å, Edlund P-O, Sjöberg K, Tjernberg A. Improved identification of host cell proteins in a protein biopharmaceutical by LC–MS/MS using the ProteoMiner™ Enrichment Kit. J Pharm Biomed Anal. 2020;185:113256. doi:10.1016/j.jpba.2020.113256.
   PubMed Web of Science ®Google Scholar
• Chen IH, Xiao H, Li N. Improved host cell protein analysis in monoclonal antibody products through ProteoMiner. Anal Biochem. 2020;2020:113972. doi:10.1016/j.ab.2020.113972.
   Google Scholar
• Yang F, Walker DE, Schoenfelder J, Carver J, Zhang A, Li D, Harris R, Stults JT, Yu XC, Michels DA. A 2D LC-MS/MS strategy for reliable detection of 10-ppm level residual host cell proteins in therapeutic antibodies. Anal Chem. 2018;90(22):13365–72. doi:10.1021/acs.analchem.8b03044.
   PubMed Web of Science ®Google Scholar
• Johnson ROB, Greer T, Cejkov M, Zheng X, Li N. Combination of FAIMS, protein a depletion, and native digest conditions enables deep proteomic profiling of host cell proteins in monoclonal antibodies. Anal Chem. 2020;92(15):10478–84. doi:10.1021/acs.analchem.0c01175.
   PubMed Web of Science ®Google Scholar
• Ma J, Sensitive KG. Rapid, rOBUST, AND REPRODUCIBLE WORKFLOW FOR HOST CELL PROTEIN PROFILING IN BIOPHARMACEUTICAL PROCESS DEVELOpment. J Proteome Res. 2020;19(8):3396–404. doi:10.1021/acs.jproteome.0c00252.
   PubMed Web of Science ®Google Scholar
• Farrell A, Mittermayr S, Morrissey B, Mc Loughlin N, Navas Iglesias N, Marison IW, Bones J. Quantitative host cell protein analysis using two dimensional data independent LC–MSE. Anal Chem. 2015;87(18):9186–93. doi:10.1021/acs.analchem.5b01377.
   PubMed Web of Science ®Google Scholar
• Jawa V, Joubert MK, Zhang Q, Deshpande M, Hapuarachchi S, Hall MP, Flynn GC. Evaluating immunogenicity risk due to host cell protein impurities in antibody-based biotherapeutics. Aaps J. 2016;18(6):1439–52. doi:10.1208/s12248-016-9948-4.
   PubMed Web of Science ®Google Scholar
• Hansen FM, Tanzer MC, Brüning F, Bludau I, Stafford C, Schulman BA, Robles MS, Karayel O, Mann M. Data-independent acquisition method for ubiquitinome analysis reveals regulation of circadian biology. Nat Commun. 2021;12(1):254. doi:10.1038/s41467-020-20509-1.
   PubMed Web of Science ®Google Scholar
• Bache N, Geyer PE, Bekker-Jensen DB, Hoerning O, Falkenby L, Treit PV, Doll S, Paron I, Müller JB, Meier F, et al. A novel LC system embeds analytes in pre-formed gradients for rapid, ultra-robust proteomics. Molecular & Cellular Proteomics: MCP. 2018;17(11):2284–96. doi:10.1074/mcp.TIR118.000853.
   PubMed Web of Science ®Google Scholar
• Bian Y, Zheng R, Bayer FP, Wong C, Chang Y-C, Meng C, Zolg DP, Reinecke M, Zecha J, Wiechmann S, et al. Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC–MS/MS. Nat Commun. 2020;11(1):157. doi:10.1038/s41467-019-13973-x.
   PubMed Web of Science ®Google Scholar
• Christianson CC, Johnson CJ, Needham SR. The advantages of microflow LC–MS/MS compared with conventional HPLC–MS/MS for the analysis of methotrexate from human plasma. Bioanalysis. 2013;5(11):1387–96. doi:10.4155/bio.13.73.
   PubMed Web of Science ®Google Scholar
• Satkunanathan S, Wheeler J, Thorpe R, Zhao Y. Establishment of a novel cell line for the enhanced production of recombinant adeno-associated virus vectors for gene therapy. Hum Gene Ther. 2014;25(11):929–41. doi:10.1089/hum.2014.041.
   PubMed Web of Science ®Google Scholar
• Strobel B, Miller FD, Rist W, Lamla T. Comparative analysis of cesium chloride- and iodixanol-based purification of recombinant adeno-associated viral vectors for preclinical applications. Hum Gene Ther Methods. 2015;26(4):147–57. doi:10.1089/hgtb.2015.051.
   PubMed Web of Science ®Google Scholar
• Vialaret J, Picas A, Delaby C, Bros P, Lehmann S, Hirtz C. Nano-flow vs standard-flow: which is the more suitable LC/MS method for quantifying hepcidin-25 in human serum in routine clinical settings? J Chromatogr B. 2018;1086:110–17. doi:10.1016/j.jchromb.2018.04.003.
   PubMed Web of Science ®Google Scholar
• Zhang M, An B, Qu Y, Shen S, Fu W, Chen YJ, Wang X, Young R, Canty JM, Balthasar JP, et al. Sensitive, high-throughput, and robust trapping-micro-LC-MS strategy for the quantification of biomarkers and antibody biotherapeutics. Anal Chem. 2018;90(3):1870–80. doi:10.1021/acs.analchem.7b03949.
   PubMed Web of Science ®Google Scholar
• Qu M, An B, Shen S, Zhang M, Shen X, Duan X, Balthasar JP, Qu J. Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry. Mass Spectrom Rev. 2017;36(6):734–54. doi:10.1002/mas.21500.
   PubMed Web of Science ®Google Scholar
• FDA. ICH Q2B validation of analytical procedures: methodology. FDA-1996-D-0169 1997.
   Google Scholar
• Gillet LC, Navarro P, Tate S, Röst H, Selevsek N, Reiter L, Bonner R, Aebersold R. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Molecular & Cellular Proteomics: MCP. 2012;11(6):11. doi:10.1074/mcp.O111.016717.
   Web of Science ®Google Scholar
• Ludwig C, Gillet L, Rosenberger G, Amon S, Collins BC, Aebersold R. Data-independent acquisition-based SWATH-MS for quantitative proteomics: a tutorial. Mol Syst Biol. 2018;14(8):e8126. doi:10.15252/msb.20178126.
   PubMed Web of Science ®Google Scholar
• Zhang F, Ge W, Ruan G, Cai X, Guo T. Data-independent acquisition mass spectrometry-based proteomics and software tools: a glimpse in 2020. Proteomics. 2020;20(17–18):1900276. doi:10.1002/pmic.201900276.
   Web of Science ®Google Scholar
• Silva JC, Gorenstein MV, Li G-Z, Vissers JPC, Geromanos SJ. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Molecular & Cellular Proteomics: MCP. 2006;5(1):144. doi:10.1074/mcp.M500230-MCP200.
   PubMed Web of Science ®Google Scholar
• Kreimer S, Gao Y, Ray S, Jin M, Tan Z, Mussa NA, Tao L, Li Z, Ivanov AR, Karger BL. Host cell protein profiling by targeted and untargeted analysis of data independent acquisition mass spectrometry data with parallel reaction monitoring verification. Anal Chem. 2017;89(10):5294–302. doi:10.1021/acs.analchem.6b04892.
   PubMed Web of Science ®Google Scholar
• Heissel S, Bunkenborg J, Kristiansen MP, Holmbjerg AF, Grimstrup M, Mørtz E, Kofoed T, Højrup P. Evaluation of spectral libraries and sample preparation for DIA-LC-MS analysis of host cell proteins: a case study of a bacterially expressed recombinant biopharmaceutical protein. Protein Expr Purif. 2018;147:69–77. doi:10.1016/j.pep.2018.03.002.
   PubMed Web of Science ®Google Scholar
• Husson G, Delangle A, O’Hara J, Cianferani S, Gervais A, Van Dorsselaer A, Bracewell D, Carapito C. Dual data-independent acquisition approach combining global HCP Profiling and absolute quantification of key impurities during bioprocess development. Anal Chem. 2018;90(2):1241–47. doi:10.1021/acs.analchem.7b03965.
   PubMed Web of Science ®Google Scholar
• Pythoud N, Bons J, Mijola G, Beck A, Cianférani S, Carapito C. Optimized sample preparation and data processing of data-independent acquisition methods for the robust quantification of trace-level host cell protein impurities in antibody drug products. J Proteomics Res. 2021;20(1):923–31. doi:10.1021/acs.jproteome.0c00664.
   PubMed Web of Science ®Google Scholar
• Picotti P, Aebersold R. Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions. Nat Methods. 2012;9(6):555–66. doi:10.1038/nmeth.2015.
   PubMed Web of Science ®Google Scholar
• Peterson AC, Russell JD, Bailey DJ, Westphall MS, Coon JJ. Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol Cell Proteom. 2012;11(11):1475–88. doi:https://doi.org/10.1074/mcp.O112.020131.
   PubMed Web of Science ®Google Scholar
• Vidova V, Spacil Z. A review on mass spectrometry-based quantitative proteomics: targeted and data independent acquisition. Anal Chim Acta. 2017;964:7–23. doi:10.1016/j.aca.2017.01.059.
   PubMed Web of Science ®Google Scholar
• Gallien S, Duriez E, Crone C, Kellmann M, Moehring T, Domon B. Targeted proteomic quantification on quadrupole-orbitrap mass spectrometer. Molecular & Cellular Proteomics: MCP. 2012;11(12):1709–23. doi:10.1074/mcp.O112.019802.
   PubMed Web of Science ®Google Scholar
• Rauniyar N. Parallel reaction monitoring: a targeted experiment performed using high resolution and high mass accuracy mass spectrometry. Int J Mol Sci. 2015;16(12):28566–81. doi:10.3390/ijms161226120.
   PubMed Web of Science ®Google Scholar
• Ronsein GE, Pamir N, von Haller PD, Kim DS, Oda MN, Jarvik GP, Vaisar T, Heinecke JW. Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics. J Proteomics. 2015;113:388–99. doi:10.1016/j.jprot.2014.10.017.
   PubMed Web of Science ®Google Scholar
• Schiffmann C, Hansen R, Baumann S, Kublik A, Nielsen PH, Adrian L, von Bergen M, Jehmlich N, Seifert J. Comparison of targeted peptide quantification assays for reductive dehalogenases by selective reaction monitoring (SRM) and precursor reaction monitoring (PRM). Anal Bioanal Chem. 2014;406(1):283–91. doi:10.1007/s00216-013-7451-7.
   PubMed Web of Science ®Google Scholar
• Gao X, Rawal B, Wang Y, Li X, Wylie D, Liu Y-H, Breunig L, Driscoll D, Wang F, Richardson DD. Targeted host cell protein quantification by LC–MRM enables biologics processing and product characterization. Anal Chem. 2020;92(1):1007–15. doi:10.1021/acs.analchem.9b03952.
   PubMed Web of Science ®Google Scholar
• Nesvizhskii AI, Vitek O, Aebersold R. Analysis and validation of proteomic data generated by tandem mass spectrometry. Nat Methods. 2007;4(10):787–97. doi:10.1038/nmeth1088.
   PubMed Web of Science ®Google Scholar
• Valente KN, Lenhoff AM, Lee KH. Expression of difficult-to-remove host cell protein impurities during extended Chinese hamster ovary cell culture and their impact on continuous bioprocessing. Biotechnol Bioeng. 2015;112(6):1232–42. doi:https://doi.org/10.1002/bit.25515.
   PubMed Web of Science ®Google Scholar
• Sim KH, Liu L-Y, Tan HT, Tan K, Ng D, Zhang W, Yang Y, Tate S, Bi X. A comprehensive CHO SWATH-MS spectral library for robust quantitative profiling of 10,000 proteins. Sci Data. 2020;7(1):263. doi:10.1038/s41597-020-00594-z.
   PubMed Web of Science ®Google Scholar
• Joucla G, Le Senechal C, Begorre M, Garbay B, Santarelli X, Cabanne C. Cation exchange versus multimodal cation exchange resins for antibody capture from CHO supernatants: identification of contaminating host cell proteins by mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;942-943:126–33. doi:10.1016/j.jchromb.2013.10.033.
   PubMed Web of Science ®Google Scholar
• Liu X, Chen Y, Zhao Y, Liu-Compton V, Chen W, Payne G, Lazar AC. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process. J Pharm Biomed Anal. 2019;174:500–08. doi:10.1016/j.jpba.2019.06.021.
   PubMed Web of Science ®Google Scholar
• Müller B, Heinrich C, Jabs W, Kaspar-Schönefeld S, Schmidt A, Rodrigues de Carvalho N, Albaum SP, Baessmann C, Noll T, Hoffrogge R. Label-free protein quantification of sodium butyrate treated CHO cells by ESI-UHR-TOF-MS. J Biotechnol. 2017;257:87–98. doi:10.1016/j.jbiotec.2017.03.032.
   PubMed Web of Science ®Google Scholar
• Zhang S, Xiao H, Molden R, Qiu H, Li N. Rapid polysorbate 80 degradation by liver carboxylesterase in a monoclonal antibody formulated drug substance at early stage development. J Pharm Sci. 2020;109(11):3300–07. doi:10.1016/j.xphs.2020.07.018.
   PubMed Web of Science ®Google Scholar
• Chiverton LM, Evans C, Pandhal J, Landels AR, Rees BJ, Levison PR, Wright PC, Smales CM. Quantitative definition and monitoring of the host cell protein proteome using iTRAQ – a study of an industrial mAb producing CHO-S cell line. Biotechnol J. 2016;11(8):1014–24. doi:10.1002/biot.201500550.
   PubMed Web of Science ®Google Scholar
• Elias JE, Gygi SP. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods. 2007;4(3):207–14. doi:10.1038/nmeth1019.
   PubMed Web of Science ®Google Scholar
• He K, Fu Y, Zeng W-F, Luo L, Chi H, Liu C, Qing L-Y, Sun R-X, He S-M. A theoretical foundation of the target-decoy search strategy for false discovery rate control in proteomics. arXiv. 2015. doi:10.48550/arXiv.1501.00537.
   Google Scholar
• Midha MK, Kusebauch U, Shteynberg D, Kapil C, Bader SL, Reddy PJ, Campbell DS, Baliga NS, Moritz RL. A comprehensive spectral assay library to quantify the Escherichia coli proteome by DIA/SWATH-MS. Sci Data. 2020;7(1):389. doi:10.1038/s41597-020-00724-7.
   PubMed Web of Science ®Google Scholar
• Blattmann P, Stutz V, Lizzo G, Richard J, Gut P, Aebersold R. Generation of a zebrafish SWATH-MS spectral library to quantify 10,000 proteins. Sci Data. 2019;6(1):190011. doi:10.1038/sdata.2019.11.
   PubMedGoogle Scholar
• Rosenberger G, Bludau I, Schmitt U, Heusel M, Hunter CL, Liu Y, MacCoss MJ, MacLean BX, Nesvizhskii AI, Pedrioli PGA, et al. Statistical control of peptide and protein error rates in large-scale targeted data-independent acquisition analyses. Nat Methods. 2017;14(9):921–27. doi:10.1038/nmeth.4398.
   PubMed Web of Science ®Google Scholar
• Navarro P, Kuharev J, Gillet LC, Bernhardt OM, MacLean B, Röst HL, Tate SA, Tsou C-C, Reiter L, Distler U, et al. A multicenter study benchmarks software tools for label-free proteome quantification. Nat Biotechnol. 2016;34:1130–36. doi:10.1038/nbt.3685.
   PubMed Web of Science ®Google Scholar
• MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, Kern R, Tabb DL, Liebler DC, McCoss MJ. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics. 2010;26:966–68. doi:10.1093/bioinformatics/btq054.
   PubMed Web of Science ®Google Scholar
• Bruderer R, Bernhardt OM, Gandhi T, Miladinović SM, Cheng LY, Messner S, Ehrenberger T, Zanotelli V, Butscheid Y, Escher C, et al. Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues. Molecular & Cellular Proteomics: MCP. 2015;14:1400–10. doi:10.1074/mcp.M114.044305.
   PubMed Web of Science ®Google Scholar
• Colangelo C, Chung L, Bruce C, Cheung K. Review of software tools for design and analysis of large scale MRM proteomic datasets. Methods (San Diego, Calif). 2013:61. doi:10.1016/j.ymeth.2013.05.004.
   Google Scholar
• Briscoe CJ, Stiles MR, Hage DS. System suitability in bioanalytical LC/MS/MS. J Pharm Biomed Anal. 2007;44:484–91. doi:10.1016/j.jpba.2007.03.003.
   PubMed Web of Science ®Google Scholar
• FDA. Guidance for industry: analytical procedures and methods validation for drugs and biologics. 2015: FDA-2015-N-0007.
   Google Scholar
• Thompson M, Wood R. Harmonized guidelines for internal quality control in analytical chemistry laboratories (Technical Report). Pure Appl Chem. 1995;67:649–66. doi:10.1351/pac199567040649.
   Web of Science ®Google Scholar
• Trauchessec M, Hesse AM, Kraut A, Berard Y, Herment L, Fortin T, Bruley C, Ferro M, Manin C. An innovative standard for LC-MS-based HCP profiling and accurate quantity assessment: application to batch consistency in viral vaccine samples. PROTEOMICS. 2021;21:2000152. doi:10.1002/pmic.202000152.
   Web of Science ®Google Scholar
• Bereman MS, Beri J, Sharma V, Nathe C, Eckels J, MacLean B, McCoss MJ. An automated pipeline to monitor system performance in liquid chromatography–tandem mass spectrometry proteomic experiments. J Proteome Res. 2016;15:4763–69. doi:10.1021/acs.jproteome.6b00744.
   PubMed Web of Science ®Google Scholar
• Li X, Chandra D, Letarte S, Adam GC, Welch J, Yang RS, Rivera S, Bodea S, Dow A, Chi A, et al. Profiling active enzymes for polysorbate degradation in biotherapeutics by activity-based protein profiling. Anal Chem. 2021;93:8161–69. doi:10.1021/acs.analchem.1c00042.
   PubMed Web of Science ®Google Scholar
• Ren D. Advancing mass spectrometry technology in cGMP environments. Trends Biotechnol. 2020;38:1051–53. doi:10.1016/j.tibtech.2020.06.007.
   PubMed Web of Science ®Google Scholar